Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Venous Thromboembolism 4 Venous Thrombosis 2 Thromboembolism 2 Lung Neoplasms 2 Pulmonary Embolism 1 Pancreatic Neoplasms 1 Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorouracil 72 Leucovorin 71 Oxaliplatin 47 Irinotecan 31 Capecitabine 24 Bevacizumab 23 Folfox protocol 20 Cetuximab 15 Chemotherapy, Adjuvant 13 Celecoxib 7 Aspirin 6 Laparoscopy 5 XELOX 4 Panitumumab 4 Neoadjuvant Therapy 4 Levamisole 4 dehydroftorafur 3 Tegafur 3 Surgical Procedures, Operative 3 Observation 3 Floxuridine 3 vatalanib 2 tislelizumab 2 pertuzumab 2 encorafenib 2 atezolizumab 2 Trastuzumab 2 Standard of Care 2 Semaxinib 2 Selenium 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colonic Neoplasms × Tinzaparin × Clear all

NCT01455831 2021-05-17

PERIOP-01

Ottawa Hospital Research Institute

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡